Ocuphire Pharma
zeta of subjects with binocular improvement worsening in at | Ocuphire Pharma
Company
Deck Type
Deck date
May 2023
Slide
15 of 27
Similar slides by Ocuphire Pharma
See diffirences between slides (animation)
Investor Presentation
August 2023
percent of subjects with binocular improvement or worsening in at ses | Ocuphire Pharma
Related slides by other companies
Neumora Therapeutics
IPO
September 2023
demonstrated statistically significant and clinically meaningful improvements in depression and anhedonia despite inclusion of mild patients | Neumora Therapeutics
DICE Therapeutics
Results
October 2022
demonstrated a favorable safety and tolerability profile in occurring in subjects in sad mad dice | DICE Therapeutics
MindMed
Investor Presentation
December 2024
potential demonstrated in gad patients with depression | MindMed
Freshpet
Results
February 2025
basis point improvement in demonstrated our ability to deliver margin targets again | Freshpet
Other recent decks by Ocuphire Pharma
See all presentations (10 decks)
Investor Presentation
November 2023
Investor Presentation
August 2023
Results
January 2023
Results
October 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights